The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Larocop 20 mg/ml Suspension for injection

20 milligram(s)/millilitre Suspension for injection

Chanelle Pharmaceuticals Manufacturing LimitedVPA10987/025/001

Main Information

Trade NameLarocop 20 mg/ml Suspension for injection
Active SubstancesCopper methionate
Strength20 milligram(s)/millilitre
Dosage FormSuspension for injection
Licence HolderChanelle Pharmaceuticals Manufacturing Limited
Licence NumberVPA10987/025/001

Group Information

ATC CodeQA12CX Other mineral products
Therapeutic ClassVitamins and minerals


Licence Issued01/10/1991
Legal StatusLM: Licensed Merchant as defined in relevant national legislation


Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back